Ondrej Suchanek

Ondrej Suchanek

Auto-generated profile, based on publicly available information

Ondrej Suchanek

Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Science
Verified
Journal Article
Open access
CSChenqu Suo
Chenqu Suo
EDEmma Dann
Emma Dann
IGIssac Goh
Issac Goh
LJLaura Jardine
Laura Jardine
VKVitalii Kleshchevnikov
Vitalii Kleshchevnikov
STSarah A. Teichmann
Sarah A. Teichmann
Single-cell genomics studies have decoded the immune cell composition of several human prenatal organs but were limited in describing the developing immune system as a distributed network across tissues. We profiled nine prenatal tissues combining single-cell RNA sequencing, antigen-receptor sequencing, and spatial transcriptomics to reconstruct the developing human immune system. This revealed the late acquisition of immune-effector functions by myeloid and lymphoid cell subsets and the maturation of monocytes and T cells before peripheral tissue seeding. Moreover, we uncovered system-wide blood and immune cell development beyond primary hematopoietic organs, characterized human prenatal B1 cells, and shed light on the origin of unconventional T cells. Our atlas provides both valuable data resources and biological insights that will facilitate cell engineering, regenerative medicine, and disease understanding.

17 February 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
KJKylie Renee James
Kylie Renee James
TGTomas Gomes
Tomas Gomes
RERasa Elmentaite
Rasa Elmentaite
NKNitin Kumar
Nitin Kumar
EGEmily L. Gulliver
Emily L. Gulliver
STSarah A. Teichmann
Sarah A. Teichmann

4 November 2020 in Nature
Verified
Journal Article
Closed access
PDF file
ZFZachary Fitzpatrick
Zachary Fitzpatrick
GFGordon Frazer
Gordon Frazer
AFAshley Ferro
Ashley Ferro
SCSimon Clare
Simon Clare
NBNicolas Bouladoux
Nicolas Bouladoux
MCMenna R. Clatworthy
Menna R. Clatworthy

23 October 2014 in Blood
Verified
Journal Article
Open access
PDF file
EWElizabeth F. Wallin
Elizabeth F. Wallin
EJElaine C. Jolly
Elaine C. Jolly
OSOndřej Suchánek
Ondřej Suchánek
JBJ. Andrew Bradley
J. Andrew Bradley
MEMarion Espéli
Marion Espéli
KSKenneth G. C. Smith
Kenneth G. C. Smith
Key Points: RTX treatment results in loss of human GC B cells. Human Tfh and Tfr cells do not require GC B cells for their maintenance.

4 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
OSOndrej Suchanek
Ondrej Suchanek
JFJohn R. Ferdinand
John R. Ferdinand
ZTZewen Tuong
Zewen Tuong
SWSathi Wijeyesinghe
Sathi Wijeyesinghe
ACAnita Chandra
Anita Chandra
MCMenna R. Clatworthy
Menna R. Clatworthy
B cells play a central role in humoral immunity but also have antibody-independent functions. Studies to date have focused on B cells in blood and secondary lymphoid organs but whether B cells reside in non-lymphoid organs (NLO) in homeostasis is unknown. Here we identify, using intravenous labeling and parabiosis, a bona-fide tissue-resident B cell population in lung, liver, kidney and urinary bladder, a substantial proportion of which are B-1a cells. Tissue-resident B cells are present in neonatal tissues and also in germ-free mice NLOs, albeit in lower numbers than in specific pathogen-free mice and following co-housing with ‘pet-store’ mice. They spatially co-localise with macrophages and regulate their polarization and function, promoting an anti-inflammatory phenotype, in-part via interleukin-10 production, with effects on bacterial clearance during urinary tract infection. Thus, our data reveal a critical role for tissue-resident B cells in determining the homeostatic ‘inflammatory set-point’ of myeloid cells, with important consequences for tissue immunity.

2 September 2015 in BMJ Quality Improvement Reports
Verified
Journal Article
Open access
PDF file
ACAynsley Cresswell
Aynsley Cresswell
MHMatthew Hart
Matthew Hart
OSOndrej Suchanek
Ondrej Suchanek
TYTania Young
Tania Young
LLLaurence Leaver
Laurence Leaver
SHStephen Hibbs
Stephen Hibbs
Foundation year doctors (FYDs) write most hospital discharge communication, although they have minimal training in this skill. Poor quality discharge summaries increase the risk of adverse events and rehospitalisation. With a multidisciplinary team approach, we developed a list of "golden rules" for good discharge communication. Against these standards, we analysed the quality of electronic inpatient discharge documentation (eIDD) sent over two months from OUH Trust. We found one third of eIDDs were missing details of the discharging doctor. In 68%, changes to medications were not documented clearly and follow-up was not completed in 40%. To improve this suboptimal state, we implemented interactive teaching sessions for FYDs, designed an e-learning module, and suggested software changes to the current electronic discharge proforma. Early re-audit one month after the first teaching sessions did not demonstrate any significant improvement. However, re-auditing after twelve months is planned. Through data collection and discussion with key stakeholders, we have identified standards for discharge communication. We developed interventions to help the trust achieve these standards, aiming to enhance patient safety in the peri-discharge period. While discharge communication is delegated to less-experienced team members, they should receive clear guidance and training.